Benjamin P. Falit
About
In The Last Decade
Benjamin P. Falit
14 papers receiving 319 citations
Peers
Comparison fields: 5 of 68
- Economics and Econometrics 128
- Radiology, Nuclear Medicine and Imaging 92
- Public Health, Environmental and Occupational Health 68
- Oncology 56
- Pediatrics, Perinatology and Child Health 53
Countries citing papers authored by Benjamin P. Falit
This map shows the geographic impact of Benjamin P. Falit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin P. Falit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin P. Falit more than expected).
Fields of papers citing papers by Benjamin P. Falit
This network shows the impact of papers produced by Benjamin P. Falit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin P. Falit. The network helps show where Benjamin P. Falit may publish in the future.
Co-authorship network of co-authors of Benjamin P. Falit
This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin P. Falit. A scholar is included among the top collaborators of Benjamin P. Falit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin P. Falit. Benjamin P. Falit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 71 | |
| 3 | 18 | |
| 4 | 3 | |
| 5 | 32 | |
| 6 | 16 | |
| 7 | 2 | |
| 8 | 45 | |
| 9 | 3 | |
| 10 | 104 | |
| 11 | 22 | |
| 12 | Twisting the truth: tinkering with patient decision aids to reduce health care expenditures. | 2 |
| 13 | Curbing Industry Sponsor's Incentive to Design Post-Approval Trials That Are Suboptimal for Informing Prescribers but More Likely than Optimal Designs to Yield Favorable Results | 5 |
| 14 | The path to cheaper and safer drugs: revamping the pharmaceutical industry in light of GlaxosmithKline's settlement. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.